{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: langchain-community in ./.venv/lib/python3.13/site-packages (0.3.7)\n",
      "Requirement already satisfied: PyYAML>=5.3 in ./.venv/lib/python3.13/site-packages (from langchain-community) (6.0.2)\n",
      "Requirement already satisfied: SQLAlchemy<2.0.36,>=1.4 in ./.venv/lib/python3.13/site-packages (from langchain-community) (2.0.35)\n",
      "Requirement already satisfied: aiohttp<4.0.0,>=3.8.3 in ./.venv/lib/python3.13/site-packages (from langchain-community) (3.11.7)\n",
      "Requirement already satisfied: dataclasses-json<0.7,>=0.5.7 in ./.venv/lib/python3.13/site-packages (from langchain-community) (0.6.7)\n",
      "Requirement already satisfied: httpx-sse<0.5.0,>=0.4.0 in ./.venv/lib/python3.13/site-packages (from langchain-community) (0.4.0)\n",
      "Requirement already satisfied: langchain<0.4.0,>=0.3.7 in ./.venv/lib/python3.13/site-packages (from langchain-community) (0.3.7)\n",
      "Requirement already satisfied: langchain-core<0.4.0,>=0.3.17 in ./.venv/lib/python3.13/site-packages (from langchain-community) (0.3.19)\n",
      "Requirement already satisfied: langsmith<0.2.0,>=0.1.125 in ./.venv/lib/python3.13/site-packages (from langchain-community) (0.1.144)\n",
      "Requirement already satisfied: numpy<2.0.0,>=1.26.0 in ./.venv/lib/python3.13/site-packages (from langchain-community) (1.26.4)\n",
      "Requirement already satisfied: pydantic-settings<3.0.0,>=2.4.0 in ./.venv/lib/python3.13/site-packages (from langchain-community) (2.6.1)\n",
      "Requirement already satisfied: requests<3,>=2 in ./.venv/lib/python3.13/site-packages (from langchain-community) (2.32.3)\n",
      "Requirement already satisfied: tenacity!=8.4.0,<10,>=8.1.0 in ./.venv/lib/python3.13/site-packages (from langchain-community) (9.0.0)\n",
      "Requirement already satisfied: aiohappyeyeballs>=2.3.0 in ./.venv/lib/python3.13/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain-community) (2.4.3)\n",
      "Requirement already satisfied: aiosignal>=1.1.2 in ./.venv/lib/python3.13/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain-community) (1.3.1)\n",
      "Requirement already satisfied: attrs>=17.3.0 in ./.venv/lib/python3.13/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain-community) (24.2.0)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in ./.venv/lib/python3.13/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain-community) (1.5.0)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in ./.venv/lib/python3.13/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain-community) (6.1.0)\n",
      "Requirement already satisfied: propcache>=0.2.0 in ./.venv/lib/python3.13/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain-community) (0.2.0)\n",
      "Requirement already satisfied: yarl<2.0,>=1.17.0 in ./.venv/lib/python3.13/site-packages (from aiohttp<4.0.0,>=3.8.3->langchain-community) (1.18.0)\n",
      "Requirement already satisfied: marshmallow<4.0.0,>=3.18.0 in ./.venv/lib/python3.13/site-packages (from dataclasses-json<0.7,>=0.5.7->langchain-community) (3.23.1)\n",
      "Requirement already satisfied: typing-inspect<1,>=0.4.0 in ./.venv/lib/python3.13/site-packages (from dataclasses-json<0.7,>=0.5.7->langchain-community) (0.9.0)\n",
      "Requirement already satisfied: langchain-text-splitters<0.4.0,>=0.3.0 in ./.venv/lib/python3.13/site-packages (from langchain<0.4.0,>=0.3.7->langchain-community) (0.3.2)\n",
      "Requirement already satisfied: pydantic<3.0.0,>=2.7.4 in ./.venv/lib/python3.13/site-packages (from langchain<0.4.0,>=0.3.7->langchain-community) (2.10.0)\n",
      "Requirement already satisfied: jsonpatch<2.0,>=1.33 in ./.venv/lib/python3.13/site-packages (from langchain-core<0.4.0,>=0.3.17->langchain-community) (1.33)\n",
      "Requirement already satisfied: packaging<25,>=23.2 in ./.venv/lib/python3.13/site-packages (from langchain-core<0.4.0,>=0.3.17->langchain-community) (24.2)\n",
      "Requirement already satisfied: typing-extensions>=4.7 in ./.venv/lib/python3.13/site-packages (from langchain-core<0.4.0,>=0.3.17->langchain-community) (4.12.2)\n",
      "Requirement already satisfied: httpx<1,>=0.23.0 in ./.venv/lib/python3.13/site-packages (from langsmith<0.2.0,>=0.1.125->langchain-community) (0.27.2)\n",
      "Requirement already satisfied: orjson<4.0.0,>=3.9.14 in ./.venv/lib/python3.13/site-packages (from langsmith<0.2.0,>=0.1.125->langchain-community) (3.10.11)\n",
      "Requirement already satisfied: requests-toolbelt<2.0.0,>=1.0.0 in ./.venv/lib/python3.13/site-packages (from langsmith<0.2.0,>=0.1.125->langchain-community) (1.0.0)\n",
      "Collecting python-dotenv>=0.21.0 (from pydantic-settings<3.0.0,>=2.4.0->langchain-community)\n",
      "  Using cached python_dotenv-1.0.1-py3-none-any.whl.metadata (23 kB)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in ./.venv/lib/python3.13/site-packages (from requests<3,>=2->langchain-community) (3.4.0)\n",
      "Requirement already satisfied: idna<4,>=2.5 in ./.venv/lib/python3.13/site-packages (from requests<3,>=2->langchain-community) (3.10)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in ./.venv/lib/python3.13/site-packages (from requests<3,>=2->langchain-community) (2.2.3)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in ./.venv/lib/python3.13/site-packages (from requests<3,>=2->langchain-community) (2024.8.30)\n",
      "Requirement already satisfied: anyio in ./.venv/lib/python3.13/site-packages (from httpx<1,>=0.23.0->langsmith<0.2.0,>=0.1.125->langchain-community) (4.6.2.post1)\n",
      "Requirement already satisfied: httpcore==1.* in ./.venv/lib/python3.13/site-packages (from httpx<1,>=0.23.0->langsmith<0.2.0,>=0.1.125->langchain-community) (1.0.7)\n",
      "Requirement already satisfied: sniffio in ./.venv/lib/python3.13/site-packages (from httpx<1,>=0.23.0->langsmith<0.2.0,>=0.1.125->langchain-community) (1.3.1)\n",
      "Requirement already satisfied: h11<0.15,>=0.13 in ./.venv/lib/python3.13/site-packages (from httpcore==1.*->httpx<1,>=0.23.0->langsmith<0.2.0,>=0.1.125->langchain-community) (0.14.0)\n",
      "Requirement already satisfied: jsonpointer>=1.9 in ./.venv/lib/python3.13/site-packages (from jsonpatch<2.0,>=1.33->langchain-core<0.4.0,>=0.3.17->langchain-community) (3.0.0)\n",
      "Requirement already satisfied: annotated-types>=0.6.0 in ./.venv/lib/python3.13/site-packages (from pydantic<3.0.0,>=2.7.4->langchain<0.4.0,>=0.3.7->langchain-community) (0.7.0)\n",
      "Requirement already satisfied: pydantic-core==2.27.0 in ./.venv/lib/python3.13/site-packages (from pydantic<3.0.0,>=2.7.4->langchain<0.4.0,>=0.3.7->langchain-community) (2.27.0)\n",
      "Requirement already satisfied: mypy-extensions>=0.3.0 in ./.venv/lib/python3.13/site-packages (from typing-inspect<1,>=0.4.0->dataclasses-json<0.7,>=0.5.7->langchain-community) (1.0.0)\n",
      "Using cached python_dotenv-1.0.1-py3-none-any.whl (19 kB)\n",
      "Installing collected packages: python-dotenv\n",
      "Successfully installed python-dotenv-1.0.1\n",
      "Requirement already satisfied: py2neo in ./.venv/lib/python3.13/site-packages (2021.2.4)\n",
      "Requirement already satisfied: certifi in ./.venv/lib/python3.13/site-packages (from py2neo) (2024.8.30)\n",
      "Requirement already satisfied: interchange~=2021.0.4 in ./.venv/lib/python3.13/site-packages (from py2neo) (2021.0.4)\n",
      "Requirement already satisfied: monotonic in ./.venv/lib/python3.13/site-packages (from py2neo) (1.6)\n",
      "Requirement already satisfied: packaging in ./.venv/lib/python3.13/site-packages (from py2neo) (24.2)\n",
      "Requirement already satisfied: pansi>=2020.7.3 in ./.venv/lib/python3.13/site-packages (from py2neo) (2024.11.0)\n",
      "Requirement already satisfied: pygments>=2.0.0 in ./.venv/lib/python3.13/site-packages (from py2neo) (2.18.0)\n",
      "Requirement already satisfied: six>=1.15.0 in ./.venv/lib/python3.13/site-packages (from py2neo) (1.16.0)\n",
      "Requirement already satisfied: urllib3 in ./.venv/lib/python3.13/site-packages (from py2neo) (2.2.3)\n",
      "Requirement already satisfied: pytz in ./.venv/lib/python3.13/site-packages (from interchange~=2021.0.4->py2neo) (2024.2)\n",
      "Requirement already satisfied: pillow in ./.venv/lib/python3.13/site-packages (from pansi>=2020.7.3->py2neo) (11.0.0)\n",
      "Requirement already satisfied: neo4j-driver in ./.venv/lib/python3.13/site-packages (5.26.0)\n",
      "Requirement already satisfied: pytz in ./.venv/lib/python3.13/site-packages (from neo4j-driver) (2024.2)\n",
      "Requirement already satisfied: python-dotenv in ./.venv/lib/python3.13/site-packages (1.0.1)\n"
     ]
    }
   ],
   "source": [
    "!pip install langchain-community\n",
    "!pip install py2neo\n",
    "!pip install neo4j-driver\n",
    "!pip install python-dotenv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Langchain\n",
    "from langchain_community.graphs import Neo4jGraph\n",
    "from langchain_community.vectorstores import Neo4jVector\n",
    "from langchain_openai import OpenAIEmbeddings\n",
    "from langchain.chains import RetrievalQAWithSourcesChain\n",
    "from langchain_openai import ChatOpenAI\n",
    "from langchain.prompts.prompt import PromptTemplate\n",
    "from langchain.chains import GraphCypherQAChain"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [],
   "source": [
    "import textwrap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import main\n",
    "import os"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "bolt://localhost:7687\n"
     ]
    }
   ],
   "source": [
    "# Load from environment\n",
    "main.load_dotenv('.env', override=True)\n",
    "print(os.getenv('NEO4J_URI'))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "NEO4J_URI = os.getenv('NEO4J_URI')\n",
    "NEO4J_USERNAME = os.getenv('NEO4J_USERNAME')\n",
    "NEO4J_PASSWORD = os.getenv('NEO4J_PASSWORD')\n",
    "NEO4J_DATABASE = os.getenv('NEO4J_DATABASE')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "kg = Neo4jGraph(\n",
    "    url=NEO4J_URI, username=NEO4J_USERNAME, password=NEO4J_PASSWORD, database=NEO4J_DATABASE\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Querying the Assets knowledge graph \n",
    "- Match all nodes in the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "cypher = \"\"\"\n",
    "  MATCH (n) \n",
    "  RETURN count(n)\n",
    "  \"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'count(n)': 249}]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(cypher)\n",
    "result"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Match only Client Nodes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'n': {'name': 'Pfizer'}}, {'n': {'name': 'Johnson & Johnson'}}]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cypher = \"\"\"\n",
    "    MATCH (n:Client) \n",
    "    RETURN n\n",
    "    \"\"\"\n",
    "kg.query(cypher)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'claim': {'text': 'Helps protect against 20 strains of pneumococcal disease.'}},\n",
       " {'claim': {'text': 'Treats moderate to severe plaque psoriasis in adults. (References not provided)'}},\n",
       " {'claim': {'text': 'Proven effective for adults aged 18 and older.'}},\n",
       " {'claim': {'text': 'Provides relief for rheumatoid arthritis symptoms.'}},\n",
       " {'claim': {'text': 'Significantly delays disease progression in HR+/HER2- breast cancer.'}}]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cypher = \"\"\"\n",
    "    MATCH (claim:Claim) WHERE claim.text IS NOT NULL\n",
    "    RETURN claim limit 5\n",
    "    \"\"\"\n",
    "kg.query(cypher)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "KEY"
     ]
    }
   ],
   "source": [
    "#BASE_LLM_URL = \"https://dev.lionis.ai/api/v1/llm/\"\n",
    "OPENAI_API_KEY = os.getenv('OPENAI_API_KEY')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Create Vector Index"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "kg.query(\"\"\"\n",
    "  CREATE VECTOR INDEX claim_text_embeddings IF NOT EXISTS\n",
    "  FOR (c:Claim) ON (c.claimTextEmbedding) \n",
    "  OPTIONS { indexConfig: {\n",
    "    `vector.dimensions`: 1536,\n",
    "    `vector.similarity_function`: 'cosine'\n",
    "  }}\"\"\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 495,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'id': 2,\n",
       "  'name': 'claim_text_embeddings',\n",
       "  'state': 'ONLINE',\n",
       "  'populationPercent': 100.0,\n",
       "  'type': 'VECTOR',\n",
       "  'entityType': 'NODE',\n",
       "  'labelsOrTypes': ['Claim'],\n",
       "  'properties': ['claimTextEmbedding'],\n",
       "  'indexProvider': 'vector-2.0',\n",
       "  'owningConstraint': None,\n",
       "  'lastRead': neo4j.time.DateTime(2024, 11, 28, 17, 28, 48, 336000000, tzinfo=<UTC>),\n",
       "  'readCount': 2242}]"
      ]
     },
     "execution_count": 495,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "kg.query(\"\"\"\n",
    "  SHOW VECTOR INDEXES\n",
    "  \"\"\"\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Create Embeddings and populate Vector Index"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 496,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 496,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "kg.query(\"\"\"\n",
    "    MATCH (claim:Claim) WHERE claim.text IS NOT NULL\n",
    "    WITH claim, genai.vector.encode(\n",
    "        claim.text, \n",
    "        \"OpenAI\", \n",
    "        {\n",
    "          token: $openAIKey\n",
    "        }) AS vector\n",
    "    CALL db.create.setNodeVectorProperty(claim, \"claimTextEmbedding\", vector)\n",
    "    \"\"\", \n",
    "    params={\"openAIKey\":OPENAI_API_KEY} )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 497,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'id': 3,\n",
       "  'name': 'claimTextSearch',\n",
       "  'state': 'ONLINE',\n",
       "  'populationPercent': 100.0,\n",
       "  'type': 'FULLTEXT',\n",
       "  'entityType': 'NODE',\n",
       "  'labelsOrTypes': ['Claim'],\n",
       "  'properties': ['text'],\n",
       "  'indexProvider': 'fulltext-1.0',\n",
       "  'owningConstraint': None,\n",
       "  'lastRead': neo4j.time.DateTime(2024, 11, 28, 16, 51, 5, 25000000, tzinfo=<UTC>),\n",
       "  'readCount': 2},\n",
       " {'id': 2,\n",
       "  'name': 'claim_text_embeddings',\n",
       "  'state': 'ONLINE',\n",
       "  'populationPercent': 100.0,\n",
       "  'type': 'VECTOR',\n",
       "  'entityType': 'NODE',\n",
       "  'labelsOrTypes': ['Claim'],\n",
       "  'properties': ['claimTextEmbedding'],\n",
       "  'indexProvider': 'vector-2.0',\n",
       "  'owningConstraint': None,\n",
       "  'lastRead': neo4j.time.DateTime(2024, 11, 28, 17, 28, 48, 336000000, tzinfo=<UTC>),\n",
       "  'readCount': 2242},\n",
       " {'id': 0,\n",
       "  'name': 'index_343aff4e',\n",
       "  'state': 'ONLINE',\n",
       "  'populationPercent': 100.0,\n",
       "  'type': 'LOOKUP',\n",
       "  'entityType': 'NODE',\n",
       "  'labelsOrTypes': None,\n",
       "  'properties': None,\n",
       "  'indexProvider': 'token-lookup-1.0',\n",
       "  'owningConstraint': None,\n",
       "  'lastRead': neo4j.time.DateTime(2024, 11, 28, 17, 32, 32, 220000000, tzinfo=<UTC>),\n",
       "  'readCount': 1813},\n",
       " {'id': 1,\n",
       "  'name': 'index_f7700477',\n",
       "  'state': 'ONLINE',\n",
       "  'populationPercent': 100.0,\n",
       "  'type': 'LOOKUP',\n",
       "  'entityType': 'RELATIONSHIP',\n",
       "  'labelsOrTypes': None,\n",
       "  'properties': None,\n",
       "  'indexProvider': 'token-lookup-1.0',\n",
       "  'owningConstraint': None,\n",
       "  'lastRead': neo4j.time.DateTime(2024, 11, 28, 13, 32, 20, 513000000, tzinfo=<UTC>),\n",
       "  'readCount': 9}]"
      ]
     },
     "execution_count": 497,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "kg.query(\"SHOW INDEXES\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1536"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(\"\"\"\n",
    "    MATCH (c:Claim) \n",
    "    WHERE c.text IS NOT NULL\n",
    "    RETURN c.text, c.claimTextEmbedding\n",
    "    LIMIT 1\n",
    "    \"\"\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Helps protect against 20 strains of pneumococcal disease.'"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result[0]['c.text']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[-0.010019322857260704,\n",
       " -0.004647746682167053,\n",
       " 0.01297813467681408,\n",
       " -0.03438824787735939,\n",
       " 0.01973387598991394,\n",
       " 0.02104184776544571,\n",
       " -0.013041628524661064,\n",
       " -0.015517886728048325,\n",
       " -0.03098497912287712,\n",
       " 0.00860976055264473]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result[0]['c.claimTextEmbedding'][:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1536"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(result[0]['c.claimTextEmbedding'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 339,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 339,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "kg.query(\"\"\"\n",
    "    MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim)-[:HAS_REFERENCE]->(reference:Reference),\n",
    "    (advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "    WHERE mlrStatus.status = 'fail' AND reference.text = 'No references'\n",
    "    DETACH DELETE reference\n",
    "    \"\"\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 340,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Node properties:\n",
      "Client {name: STRING}\n",
      "Brand {name: STRING}\n",
      "Advertisement {assetSubType: STRING, audience: STRING, indicationAndUsage: STRING, assetFormat: STRING, assetPurpose: STRING, fullPrescribingInformation: STRING, headline: STRING, assetURL: STRING, assetType: STRING, dimensions: STRING}\n",
      "Claim {text: STRING, claimTextEmbedding: LIST}\n",
      "Footnote {text: STRING}\n",
      "Reference {text: STRING}\n",
      "Channel {name: STRING}\n",
      "MLRStatus {status: STRING, reason: FLOAT}\n",
      "Relationship properties:\n",
      "\n",
      "The relationships:\n",
      "(:Client)-[:HAS_BRAND]->(:Brand)\n",
      "(:Brand)-[:HAS_ADVERTISEMENT]->(:Advertisement)\n",
      "(:Advertisement)-[:USES_CLAIM]->(:Claim)\n",
      "(:Advertisement)-[:DISPLAYED_ON]->(:Channel)\n",
      "(:Advertisement)-[:HAS_MLR_STATUS]->(:MLRStatus)\n",
      "(:Claim)-[:HAS_REFERENCE]->(:Reference)\n",
      "(:Claim)-[:HAS_FOOTNOTE]->(:Footnote)\n"
     ]
    }
   ],
   "source": [
    "kg.refresh_schema()\n",
    "print(kg.schema)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'advertisementDetails': {'assetFormat': 'Banner',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'audience': 'Medical Professional',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'assetSubType': 'Video',\n",
       "   'assetURL': 'https://example.com/assets/8253',\n",
       "   'dimensions': '300x250',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'indicationAndUsage': 'Vaccination'},\n",
       "  'claimText': 'Helps protect against 20 strains of pneumococcal disease.',\n",
       "  'score': 0.9763641357421875}]"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query = \"WITH genai.vector.encode($inputClaim, 'OpenAI', { token: $openAIKey }) AS inputVector \" \\\n",
    "        \"MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim), \" \\\n",
    "        \"(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus) \" \\\n",
    "        \"WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL \" \\\n",
    "        \"CALL db.index.vector.queryNodes($index_name, $top_k, inputVector) yield node, score \" \\\n",
    "        \"WITH advertisement, node, score \" \\\n",
    "        \"WHERE score > $similarityThreshold \" \\\n",
    "        \"RETURN { assetSubType: advertisement.assetSubType, audience: advertisement.audience, indicationAndUsage: advertisement.indicationAndUsage, \" \\\n",
    "        \"assetFormat: advertisement.assetFormat, assetPurpose: advertisement.assetPurpose, fullPrescribingInformation: advertisement.fullPrescribingInformation, \" \\\n",
    "        \"headline: advertisement.headline, assetURL: advertisement.assetURL, assetType: advertisement.assetType, dimensions: advertisement.dimensions } AS advertisementDetails, \" \\\n",
    "        \"node.text AS claimText, score \" \\\n",
    "        \"ORDER BY score DESC \" \\\n",
    "        \"LIMIT $limit\"\n",
    "        \n",
    "params = {\n",
    "    \"openAIKey\": OPENAI_API_KEY,\n",
    "    \"inputClaim\": \"Helps protect against 18 strains of pneumococcal disease\",\n",
    "    \"similarityThreshold\": 0.9,\n",
    "    \"index_name\": \"claim_text_embeddings\",\n",
    "    \"top_k\": 1,\n",
    "    \"limit\": 1\n",
    "}\n",
    "kg.query(query, params)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 214,
   "metadata": {},
   "outputs": [],
   "source": [
    "embeddings = OpenAIEmbeddings(openai_api_key=OPENAI_API_KEY)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 215,
   "metadata": {},
   "outputs": [],
   "source": [
    "input_vector = embeddings.embed_query(\"Helps protect against 18 strains of pneumococcal disease\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 216,
   "metadata": {},
   "outputs": [],
   "source": [
    "query = \"\"\"MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
    "CALL db.index.vector.queryNodes($index_name, $top_k, $inputVector) YIELD node, score\n",
    "WITH advertisement, node, score\n",
    "WHERE score > 0.9\n",
    "RETURN advertisement.assetSubType, advertisement.audience, advertisement.indicationAndUsage,\n",
    "advertisement.assetFormat, advertisement.assetPurpose, advertisement.fullPrescribingInformation,\n",
    "advertisement.headline, advertisement.assetURL, advertisement.assetType, advertisement.dimensions,\n",
    "node.text AS claimText, score\n",
    "ORDER BY score DESC\n",
    "LIMIT $limit\"\"\"\n",
    "\n",
    "params = {\n",
    "    \"openAIKey\": OPENAI_API_KEY,\n",
    "    \"inputVector\": input_vector,\n",
    "    \"index_name\": \"claim_text_embeddings\",\n",
    "    \"top_k\": 1,\n",
    "    \"limit\": 1\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 217,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'advertisement.assetSubType': 'Video',\n",
       "  'advertisement.audience': 'Medical Professional',\n",
       "  'advertisement.indicationAndUsage': 'Vaccination',\n",
       "  'advertisement.assetFormat': 'Banner',\n",
       "  'advertisement.assetPurpose': 'Educational',\n",
       "  'advertisement.fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "  'advertisement.headline': 'Science for a Better Life',\n",
       "  'advertisement.assetURL': 'https://example.com/assets/8253',\n",
       "  'advertisement.assetType': 'Multi Frame',\n",
       "  'advertisement.dimensions': '300x250',\n",
       "  'claimText': 'Helps protect against 20 strains of pneumococcal disease.',\n",
       "  'score': 0.9763641357421875}]"
      ]
     },
     "execution_count": 217,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "kg.query(query, params)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Similarity search and setup a RAG to interact with AssetClaim repository\n",
    "- Calculate embedding for question\n",
    "- Identify matching advertisment based on similarity of question and `claimTextEmbedding` vectors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Global constants\n",
    "VECTOR_INDEX_NAME = 'claim_text_embeddings'\n",
    "VECTOR_NODE_LABEL = 'Claim'\n",
    "VECTOR_SOURCE_PROPERTY = 'text'\n",
    "VECTOR_EMBEDDING_PROPERTY = 'claimTextEmbedding'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "neo4j_vector_store = Neo4jVector.from_existing_graph(\n",
    "    embedding=OpenAIEmbeddings(),\n",
    "    url=NEO4J_URI,\n",
    "    username=NEO4J_USERNAME,\n",
    "    password=NEO4J_PASSWORD,\n",
    "    index_name=VECTOR_INDEX_NAME,\n",
    "    node_label=VECTOR_NODE_LABEL,\n",
    "    text_node_properties=[VECTOR_SOURCE_PROPERTY],\n",
    "    embedding_node_property=VECTOR_EMBEDDING_PROPERTY,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "#retriever = neo4j_vector_store.as_retriever()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Writing Cypher with an LLM"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "In this section, we'll use few-shot learning to teach an LLM to write Cypher\n",
    "- We'll use the OpenAI's GPT 3.5 model \n",
    "- We'll also use a new Neo4j integration within LangChain called **GraphCypherQAChain**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 532,
   "metadata": {},
   "outputs": [],
   "source": [
    "CYPHER_GENERATION_TEMPLATE = \"\"\"\n",
    "Task: Generate a Cypher statement to query a graph database.\n",
    "Instructions:\n",
    "- Use only the provided relationship types and properties in the schema. Do not use any other relationship types or properties that are not provided. Consider the relationship direction as well.\n",
    "- Do not respond to any questions that might ask anything else than for you to construct a Cypher statement.\n",
    "- Ensure the generated Cypher statement is syntactically correct and compatible with Neo4j.\n",
    "- Return only the Cypher statement without explanations, apologies, or additional commentary.\n",
    "- If the query involves vector similarity, use appropriate vector-based querying methods such as `db.index.vector.queryNodes` or `genai.vector.encode`\n",
    "- If inputClaim and token are provided then use their value while generating cypher query.\n",
    "\n",
    "Schema:\n",
    "{schema}\n",
    "\n",
    "Examples: Here are a few examples of generated Cypher statements for particular questions:\n",
    "\n",
    "# Retrieve claims and details for Advertisements with MLRStatus 'pass' and a claim similar to the {inputClaim}.\n",
    "WITH genai.vector.encode(\"{inputClaim}\", 'OpenAI', {token}) AS inputVector\n",
    "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
    "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 1, inputVector) YIELD node, score\n",
    "WITH advertisement, node, score\n",
    "WHERE score > 0.9\n",
    "RETURN advertisement.assetSubType, advertisement.audience, advertisement.indicationAndUsage,\n",
    "advertisement.assetFormat, advertisement.assetPurpose, advertisement.fullPrescribingInformation,\n",
    "advertisement.headline, advertisement.assetURL, advertisement.assetType, advertisement.dimensions,\n",
    "node.text AS claimText, score\n",
    "ORDER BY score DESC\n",
    "LIMIT 1\n",
    "\n",
    "# Retrieve claims for the Advertisements for which MLRStatus is'pass' and a claim similar to the {inputClaim}.\n",
    "WITH genai.vector.encode(\"{inputClaim}\", 'OpenAI', {token}) AS inputVector\n",
    "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
    "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 1, inputVector) YIELD node, score\n",
    "WITH DISTINCT node, score\n",
    "WHERE score > 0.9\n",
    "RETURN node.text AS claimText, score\n",
    "ORDER BY score DESC\n",
    "LIMIT 1\n",
    "\n",
    "# Give me the asset URL and claim for the advertisment for which reference is missing\n",
    "MATCH (advertisement:Advertisement)\n",
    "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "OPTIONAL MATCH (claim)-[:HAS_REFERENCE]->(reference:Reference)\n",
    "WITH advertisement, claim, reference\n",
    "WHERE reference IS NULL\n",
    "RETURN advertisement.assetURL, claim.text, reference\n",
    "\n",
    "# Retrieve claims, references and asset MLR review failure reason for Advertisements with MLR Status as failure\n",
    "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "MATCH (claim)-[:HAS_REFERENCE]->(reference:Reference)\n",
    "MATCH (advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "WHERE mlrStatus.status = 'fail'\n",
    "RETURN claim.text AS claimText, reference.text AS referenceText, mlrStatus.reason\n",
    "\n",
    "# Retrive the most often used claim in any passed advertisement\n",
    "MATCH (advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "WHERE mlrStatus.status = 'pass'\n",
    "WITH claim, COUNT(advertisement) AS usageCount\n",
    "RETURN claim.text AS claimText, usageCount\n",
    "ORDER BY usageCount DESC\n",
    "LIMIT 5\n",
    "\n",
    "# Give me top 5 headlines used for client Johnson and Johnson\n",
    "MATCH (client:Client)-[:HAS_BRAND]->(:Brand)-[:HAS_ADVERTISEMENT]->(advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "WHERE client.name = 'Johnson & Johnson'and mlrStatus.status = 'pass'\n",
    "WITH advertisement\n",
    "MATCH (advertisement)-[:USES_CLAIM]->(:Claim)\n",
    "RETURN advertisement.headline AS headline, COUNT(advertisement) AS usageCount\n",
    "ORDER BY usageCount DESC\n",
    "LIMIT 5\n",
    "\n",
    "# Tell me in terms of Yes or No if this particular claim text is present for any passed advertisment. Claim text is 'Proven effective for adults aged 18 and older.'\n",
    "MATCH (advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "WHERE mlrStatus.status = 'pass' and claim.text= 'Proven effective for adults aged 18 and older.'\n",
    "RETURN CASE WHEN COUNT(*) > 0 THEN 'Yes' ELSE 'No' END AS ClaimPresentInPassedAdvertisements\n",
    "\n",
    "Question:\n",
    "{question}\n",
    "\"\"\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 533,
   "metadata": {},
   "outputs": [],
   "source": [
    "CYPHER_GENERATION_PROMPT = PromptTemplate(\n",
    "    input_variables=[\"schema\", \"question\",\"inputClaim\",\"token\"], \n",
    "    template=CYPHER_GENERATION_TEMPLATE\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 534,
   "metadata": {},
   "outputs": [],
   "source": [
    "cypherChain = GraphCypherQAChain.from_llm(\n",
    "    ChatOpenAI(temperature=0, openai_api_key=OPENAI_API_KEY),\n",
    "    graph=kg,\n",
    "    verbose=True,\n",
    "    allow_dangerous_requests=True,\n",
    "    return_direct=True,\n",
    "    cypher_prompt=CYPHER_GENERATION_PROMPT\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 467,
   "metadata": {},
   "outputs": [],
   "source": [
    "failedClaim = \"Delays disease progression in HR/HER2 cancer.\"\n",
    "question = f\"Retrieve claims and details for Advertisements with MLRStatus 'pass' and a claim similar to the input claim which is -{failedClaim}\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {},
   "outputs": [],
   "source": [
    "input_vector = embeddings.embed_query(failedClaim)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 266,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'{ token: \"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\" }'"
      ]
     },
     "execution_count": 266,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "token = f\"\"\"{{ token: \"{OPENAI_API_KEY}\" }}\"\"\"\n",
    "token"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 535,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prompt: \n",
      "Task: Generate a Cypher statement to query a graph database.\n",
      "Instructions:\n",
      "- Use only the provided relationship types and properties in the schema. Do not use any other relationship types or properties that are not provided. Consider the relationship direction as well.\n",
      "- Do not respond to any questions that might ask anything else than for you to construct a Cypher statement.\n",
      "- Ensure the generated Cypher statement is syntactically correct and compatible with Neo4j.\n",
      "- Return only the Cypher statement without explanations, apologies, or additional commentary.\n",
      "- If the query involves vector similarity, use appropriate vector-based querying methods such as `db.index.vector.queryNodes` or `genai.vector.encode`\n",
      "- If inputClaim and token are provided then use their value while generating cypher query.\n",
      "\n",
      "Schema:\n",
      "Node properties:\n",
      "Client {name: STRING}\n",
      "Brand {name: STRING}\n",
      "Advertisement {assetSubType: STRING, audience: STRING, indicationAndUsage: STRING, assetFormat: STRING, assetPurpose: STRING, fullPrescribingInformation: STRING, headline: STRING, assetURL: STRING, assetType: STRING, dimensions: STRING}\n",
      "Claim {text: STRING, claimTextEmbedding: LIST}\n",
      "Footnote {text: STRING}\n",
      "Reference {text: STRING}\n",
      "Channel {name: STRING}\n",
      "MLRStatus {status: STRING, reason: FLOAT}\n",
      "Relationship properties:\n",
      "\n",
      "The relationships:\n",
      "(:Client)-[:HAS_BRAND]->(:Brand)\n",
      "(:Brand)-[:HAS_ADVERTISEMENT]->(:Advertisement)\n",
      "(:Advertisement)-[:USES_CLAIM]->(:Claim)\n",
      "(:Advertisement)-[:DISPLAYED_ON]->(:Channel)\n",
      "(:Advertisement)-[:HAS_MLR_STATUS]->(:MLRStatus)\n",
      "(:Claim)-[:HAS_REFERENCE]->(:Reference)\n",
      "(:Claim)-[:HAS_FOOTNOTE]->(:Footnote)\n",
      "\n",
      "Examples: Here are a few examples of generated Cypher statements for particular questions:\n",
      "\n",
      "# Retrieve claims and details for Advertisements with MLRStatus 'pass' and a claim similar to the Not needed.\n",
      "WITH genai.vector.encode(\"Not needed\", 'OpenAI', { token: \"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\" }) AS inputVector\n",
      "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
      "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 1, inputVector) YIELD node, score\n",
      "WITH advertisement, node, score\n",
      "WHERE score > 0.9\n",
      "RETURN advertisement.assetSubType, advertisement.audience, advertisement.indicationAndUsage,\n",
      "advertisement.assetFormat, advertisement.assetPurpose, advertisement.fullPrescribingInformation,\n",
      "advertisement.headline, advertisement.assetURL, advertisement.assetType, advertisement.dimensions,\n",
      "node.text AS claimText, score\n",
      "ORDER BY score DESC\n",
      "LIMIT 1\n",
      "\n",
      "# Retrieve claims for the Advertisements for which MLRStatus is'pass' and a claim similar to the Not needed.\n",
      "WITH genai.vector.encode(\"Not needed\", 'OpenAI', { token: \"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\" }) AS inputVector\n",
      "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
      "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 1, inputVector) YIELD node, score\n",
      "WITH DISTINCT node, score\n",
      "WHERE score > 0.9\n",
      "RETURN node.text AS claimText, score\n",
      "ORDER BY score DESC\n",
      "LIMIT 1\n",
      "\n",
      "# Give me the asset URL and claim for the advertisment for which reference is missing\n",
      "MATCH (advertisement:Advertisement)\n",
      "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
      "OPTIONAL MATCH (claim)-[:HAS_REFERENCE]->(reference:Reference)\n",
      "WITH advertisement, claim, reference\n",
      "WHERE reference IS NULL\n",
      "RETURN advertisement.assetURL, claim.text, reference\n",
      "\n",
      "# Retrieve claims, references and asset MLR review failure reason for Advertisements with MLR Status as failure\n",
      "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
      "MATCH (claim)-[:HAS_REFERENCE]->(reference:Reference)\n",
      "MATCH (advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'fail'\n",
      "RETURN claim.text AS claimText, reference.text AS referenceText, mlrStatus.reason\n",
      "\n",
      "# Retrive the most often used claim in any passed advertisement\n",
      "MATCH (advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
      "WHERE mlrStatus.status = 'pass'\n",
      "WITH claim, COUNT(advertisement) AS usageCount\n",
      "RETURN claim.text AS claimText, usageCount\n",
      "ORDER BY usageCount DESC\n",
      "LIMIT 5\n",
      "\n",
      "# Give me top 5 headlines used for client Johnson and Johnson\n",
      "MATCH (client:Client)-[:HAS_BRAND]->(:Brand)-[:HAS_ADVERTISEMENT]->(advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE client.name = 'Johnson & Johnson'and mlrStatus.status = 'pass'\n",
      "WITH advertisement\n",
      "MATCH (advertisement)-[:USES_CLAIM]->(:Claim)\n",
      "RETURN advertisement.headline AS headline, COUNT(advertisement) AS usageCount\n",
      "ORDER BY usageCount DESC\n",
      "LIMIT 5\n",
      "\n",
      "# Tell me in terms of Yes or No if this particular claim text is present for any passed advertisment. Claim text is 'Proven effective for adults aged 18 and older.'\n",
      "MATCH (advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
      "WHERE mlrStatus.status = 'pass' and claim.text= 'Proven effective for adults aged 18 and older.'\n",
      "RETURN CASE WHEN COUNT(*) > 0 THEN 'Yes' ELSE 'No' END AS ClaimPresentInPassedAdvertisements\n",
      "\n",
      "Question:\n",
      "Give me top 5 headlines used most often in passed advertisements for the client Johnson and Johnson\n",
      "\n"
     ]
    }
   ],
   "source": [
    "prompt=CYPHER_GENERATION_PROMPT.format(schema=kg.get_schema, question=question, inputClaim=failedClaim, token=token)\n",
    "print('Prompt:', prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 309,
   "metadata": {},
   "outputs": [],
   "source": [
    "def wrap_text_in_dict(d, width=60):\n",
    "    if isinstance(d, dict):\n",
    "        return {k: wrap_text_in_dict(v, width) for k, v in d.items()}\n",
    "    elif isinstance(d, str):\n",
    "        return textwrap.fill(d, width)\n",
    "    elif isinstance(d, list):\n",
    "        return [wrap_text_in_dict(item, width) for item in d]\n",
    "    else:\n",
    "        return d  # Return non-string values as is"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 536,
   "metadata": {},
   "outputs": [],
   "source": [
    "def prettychain(question: str):\n",
    "    \"\"\"Execute the chain's response and pretty print the output.\"\"\"\n",
    "    try:\n",
    "       \n",
    "        \n",
    "        response = cypherChain.invoke({\n",
    "            \"query\": question,\n",
    "            \"token\":token,\n",
    "            \"inputClaim\": failedClaim},\n",
    "            prompt=prompt,\n",
    "            return_only_outputs = True,)\n",
    "        \n",
    "        # Formatting response for better readability\n",
    "       \n",
    "        print(response)\n",
    "        #wrapped_response = wrap_text_in_dict(response, width=60)\n",
    "        #print(wrapped_response)\n",
    "    except Exception as e:\n",
    "        print(\"An error occurred while generating the query:\")\n",
    "        print(e)\n",
    "        print(str(e))\n",
    "        return None\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 257,
   "metadata": {},
   "outputs": [],
   "source": [
    "query_params = {\n",
    "      \"question\": question,\n",
    "      \"openAIKey\": OPENAI_API_KEY,\n",
    "      \"similarityThreshold\": 0.9,\n",
    "      \"index_name\": \"claim_text_embeddings\",\n",
    "      \"top_k\": 1,\n",
    "      \"limit\": 1,\n",
    "      \"inputVector\": input_vector\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "kg.refresh_schema()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 311,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mWITH genai.vector.encode(\"Delays disease progression in HR/HER2 cancer.\", 'OpenAI', { token: \"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\" }) AS inputVector\n",
      "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
      "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 1, inputVector) YIELD node, score\n",
      "WITH advertisement, node, score\n",
      "WHERE score > 0.9\n",
      "RETURN advertisement.assetSubType, advertisement.audience, advertisement.indicationAndUsage,\n",
      "advertisement.assetFormat, advertisement.assetPurpose, advertisement.fullPrescribingInformation,\n",
      "advertisement.headline, advertisement.assetURL, advertisement.assetType, advertisement.dimensions,\n",
      "node.text AS claimText, score\n",
      "ORDER BY score DESC\n",
      "LIMIT 1\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'advertisement.assetSubType': 'Video', 'advertisement.audience': 'Medical Professional', 'advertisement.indicationAndUsage': 'Vaccination', 'advertisement.assetFormat': 'Banner', 'advertisement.assetPurpose': 'Educational', 'advertisement.fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.', 'advertisement.headline': 'Science for a Better Life', 'advertisement.assetURL': 'https://example.com/assets/8253', 'advertisement.assetType': 'Multi Frame', 'advertisement.dimensions': '300x250', 'claimText': 'Significantly delays disease progression in HR+/HER2- breast cancer.', 'score': 0.9783477783203125}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 480,
   "metadata": {},
   "outputs": [],
   "source": [
    "failedClaim = \"Helps protect against 2 strains of pneumococcal disease.\"\n",
    "question = f\"Retrieve claims for Advertisements with MLRStatus 'pass' and a claim similar to the input claim which is -{failedClaim}\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 481,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mWITH genai.vector.encode(\"Helps protect against 2 strains of pneumococcal disease.\", 'OpenAI', { token: \"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\" }) AS inputVector\n",
      "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
      "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 1, inputVector) YIELD node, score\n",
      "WITH node, score\n",
      "WHERE score > 0.9\n",
      "RETURN node.text AS claimText, score\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}, {'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9705352783203125}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 482,
   "metadata": {},
   "outputs": [],
   "source": [
    "failedClaim = \"Not needed\"\n",
    "question = f\"Retrieve claims and references for Advertisements with MLRStatus 'fail' and also give reason for failure\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 483,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mMATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
      "MATCH (claim)-[:HAS_REFERENCE]->(reference:Reference)\n",
      "MATCH (advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'fail'\n",
      "RETURN claim.text AS claimText, reference.text AS referenceText, mlrStatus.reason\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'claimText': 'Proven effective for adults aged 18 and older.', 'referenceText': 'https://www.fda.gov/drugs; https://pubmed.ncbi.nlm.nih.gov', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': 'Provides relief for rheumatoid arthritis symptoms.', 'referenceText': 'https://ard.bmj.com; https://www.rheumatology.org', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': 'Proven effective for children aged 18 and older.', 'referenceText': 'https://www.fda.gov/drugs; https://pubmed.ncbi.nlm.nih.gov', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': 'Provides relief for rheumatoid arthritis symptoms.', 'referenceText': 'https://ard.bmj.com; https://www.rheumatology.org', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': \"Effective for Crohn's disease after failure of conventional therapy.\", 'referenceText': 'https://www.thelancet.com; https://www.gastrojournal.org', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': 'Shown to reduce inflammation in ulcerative colitis.', 'referenceText': 'https://www.gastrojournal.org; https://clinicaltrials.gov', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': 'Provides relief for rheumatoid arthritis symptoms.', 'referenceText': 'https://ard.bmj.com; https://www.rheumatology.org', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': 'Provides relief for rheumatoid arthritis symptoms.', 'referenceText': 'https://ard.bmj.com; https://www.rheumatology.org', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': \"Effective for Crohn's disease after failure of conventional therapy.\", 'referenceText': 'https://www.thelancet.com; https://www.gastrojournal.org', 'mlrStatus.reason': 'Non-compliance with regulations'}, {'claimText': 'Shown to reduce inflammation in ulcerative colitis.', 'referenceText': 'https://www.gastrojournal.org; https://clinicaltrials.gov', 'mlrStatus.reason': 'Non-compliance with regulations'}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 537,
   "metadata": {},
   "outputs": [],
   "source": [
    "question = f\"Return the headline which is used most often in any passed advetisment of Johnson and Johnson and brand Stelara. Give how many times its used. Give top 5 such headline\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 538,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mMATCH (client:Client {name: 'Johnson & Johnson'})-[:HAS_BRAND]->(:Brand {name: 'Stelara'})-[:HAS_ADVERTISEMENT]->(advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'pass'\n",
      "WITH advertisement\n",
      "MATCH (advertisement)-[:USES_CLAIM]->(:Claim)\n",
      "RETURN advertisement.headline AS headline, COUNT(advertisement) AS usageCount\n",
      "ORDER BY usageCount DESC\n",
      "LIMIT 5\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'headline': 'Innovative Treatments for Tomorrow', 'usageCount': 10}, {'headline': 'Protect Your Health Today', 'usageCount': 7}, {'headline': 'Relief is Within Reach', 'usageCount': 6}, {'headline': 'Science for a Better Life', 'usageCount': 4}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 486,
   "metadata": {},
   "outputs": [],
   "source": [
    "question = f\"Give me top 5 mostly used claims for an advertisment for 'Johnson & Johnson' and brand Stelara. This advertisement is for Educational purpose with dimensions 300x250. Status of advertisements should be passed\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 487,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mMATCH (client:Client {name: 'Johnson & Johnson'})-[:HAS_BRAND]->(brand:Brand {name: 'Stelara'})\n",
      "MATCH (advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus {status: 'pass'})\n",
      "WHERE advertisement.assetPurpose = 'Educational' AND advertisement.dimensions = '300x250'\n",
      "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
      "WITH claim, COUNT(advertisement) AS usageCount\n",
      "RETURN claim.text AS claimText, usageCount\n",
      "ORDER BY usageCount DESC\n",
      "LIMIT 5\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'claimText': 'Helps protect against 20 strains of pneumococcal disease.', 'usageCount': 3}, {'claimText': 'Improves progression-free survival in combination therapy.', 'usageCount': 2}, {'claimText': 'Proven effective for adults aged 18 and older.', 'usageCount': 1}, {'claimText': \"Effective for Crohn's disease after failure of conventional therapy.\", 'usageCount': 1}, {'claimText': 'Shown to reduce inflammation in ulcerative colitis.', 'usageCount': 1}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 488,
   "metadata": {},
   "outputs": [],
   "source": [
    "question = \"Tell me in terms of Yes or No if this particular claim text is present for any passed advertisment. Claim text is 'Proven effective for adults aged 18 and older.'\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 489,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mMATCH (advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
      "WHERE mlrStatus.status = 'pass' and claim.text= 'Proven effective for adults aged 18 and older.'\n",
      "RETURN CASE WHEN COUNT(*) > 0 THEN 'Yes' ELSE 'No' END AS ClaimPresentInPassedAdvertisements\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'ClaimPresentInPassedAdvertisements': 'Yes'}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 540,
   "metadata": {},
   "outputs": [],
   "source": [
    "question = \"Give me top 5 headlines used in passed advertisements for the client Johnson and Johnson\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 541,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mMATCH (client:Client {name: 'Johnson & Johnson'})-[:HAS_BRAND]->(:Brand)-[:HAS_ADVERTISEMENT]->(advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'pass'\n",
      "RETURN advertisement.headline AS headline, COUNT(advertisement) AS usageCount\n",
      "ORDER BY usageCount DESC\n",
      "LIMIT 5\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'headline': 'Innovative Treatments for Tomorrow', 'usageCount': 16}, {'headline': 'Protect Your Health Today', 'usageCount': 14}, {'headline': 'Relief is Within Reach', 'usageCount': 9}, {'headline': 'Science for a Better Life', 'usageCount': 9}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 490,
   "metadata": {},
   "outputs": [],
   "source": [
    "question = \"Give me similar claim text which is present for any passed advertisment. Claim text is 'Proven effective for adults aged 1 and older.'\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 491,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new GraphCypherQAChain chain...\u001b[0m\n",
      "Generated Cypher:\n",
      "\u001b[32;1m\u001b[1;3mWITH genai.vector.encode(\"Proven effective for adults aged 1 and older.\", 'OpenAI', { token: \"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\" }) AS inputVector\n",
      "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
      "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
      "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 1, inputVector) YIELD node, score\n",
      "WITH claim.text AS similarClaimText, score\n",
      "WHERE score > 0.9\n",
      "RETURN similarClaimText, score\n",
      "ORDER BY score DESC\n",
      "LIMIT 1\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "{'result': [{'similarClaimText': 'Helps protect against 20 strains of pneumococcal disease.', 'score': 0.9823150634765625}]}\n"
     ]
    }
   ],
   "source": [
    "prettychain(question)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 500,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'similarClaimText': 'Proven effective for adults aged 18 and older.',\n",
       "  'score': 0.996612548828125},\n",
       " {'similarClaimText': 'Proven effective for adults aged 18 and older.',\n",
       "  'score': 0.996612548828125},\n",
       " {'similarClaimText': 'Proven effective for adults aged 18 and older.',\n",
       "  'score': 0.996612548828125},\n",
       " {'similarClaimText': 'Proven effective for adults aged 18 and older.',\n",
       "  'score': 0.996612548828125},\n",
       " {'similarClaimText': 'Proven effective for adults aged 18 and older.',\n",
       "  'score': 0.996612548828125}]"
      ]
     },
     "execution_count": 500,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(\"\"\"WITH genai.vector.encode(\"Proven effective for adults aged 18 and older.\", 'OpenAI', { token: \"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\" }) AS inputVector\n",
    "MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim),(advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "WHERE mlrStatus.status = 'pass' AND claim.claimTextEmbedding IS NOT NULL\n",
    "CALL db.index.vector.queryNodes(\"claim_text_embeddings\", 5, inputVector) YIELD node, score\n",
    "WITH node.text AS similarClaimText, score\n",
    "WHERE score > 0.9\n",
    "RETURN similarClaimText, score\n",
    "ORDER BY score DESC\n",
    "LIMIT 5\"\"\")\n",
    "\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 369,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'advertisement.assetURL': 'https://example.com/assets/8253',\n",
       "  'claim.text': 'Helps protect against 20 strains of pneumococcal disease.',\n",
       "  'reference': {'text': 'https://www.fda.gov; https://www.cdc.gov/vaccines'}},\n",
       " {'advertisement.assetURL': 'https://example.com/assets/8253',\n",
       "  'claim.text': 'Helps protect against 20 strains of pneumococcal disease.',\n",
       "  'reference': {'text': 'https://www.fda.gov; https://www.cdc.gov/vaccines'}}]"
      ]
     },
     "execution_count": 369,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(\"\"\"MATCH (advertisement:Advertisement)\n",
    "WHERE advertisement.assetURL = 'https://example.com/assets/8253'\n",
    "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "OPTIONAL MATCH (claim)-[:HAS_REFERENCE]->(reference:Reference)\n",
    "RETURN advertisement.assetURL, claim.text, reference\n",
    "\"\"\")\n",
    "\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 361,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/8253',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/8253',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/8951',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/7318',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5064',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/4552',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/2745',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/8261',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/2294',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/1585',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/8583',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/7440',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2264',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9833',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5811',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2860',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/1478',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/3008',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9187',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5149',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5149',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5360',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5722',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7443',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/6275',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/8147',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8085',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2226',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2632',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4556',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2432',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/9655',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2472',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/9700',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/9839',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/7109',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9519',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/4965',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2794',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9506',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5538',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2874',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9581',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/5551',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/2248',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/1011',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5813',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/9270',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/8149',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/7583',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/5314',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/4364',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/5021',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/9487',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/3531',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/3499',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/8109',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/3295',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/8250',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5711',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4760',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5391',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/3486',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/8272',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/3122',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2583',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/4178',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/1765',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/1413',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/9028',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/6404',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4483',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8787',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9306',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/9615',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4517',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9376',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/2877',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4096',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/1061',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/6938',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/6377',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/7426',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/1075',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5643',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8685',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/1906',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5096',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5937',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/7350',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7565',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/8767',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/8311',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5334',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/5960',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9270',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9614',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/6181',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5444',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/8186',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/3264',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5185',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/6669',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/2711',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9860',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8302',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/1849',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2167',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/9449',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2390',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/1126',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/5136',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5016',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2474',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4398',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/1952',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9929',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5487',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5248',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/7777',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7290',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4212',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/3892',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8237',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/7514',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9692',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8258',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/6766',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/4210',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9712',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/5008',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/7177',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/2299',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/6324',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7580',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8834',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9573',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/1141',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2364',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/3503',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/4122',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/1218',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/3531',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/3026',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/6057',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/2646',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/5229',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4160',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/1365',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/4931',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/3036',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9642',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8326',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5526',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9360',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/4621',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5325',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/8671',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/1937',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5501',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/1611',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2904',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/6104',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/8064',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2121',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/1018',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7331',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/5448',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/8815',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/9291',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/3086',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9041',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/8204',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5838',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2309',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/5136',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/4812',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/8221',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5015',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7560',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/8961',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/4955',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/3693',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/2003',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/9133',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/5678',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/9067',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7661',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/2436',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5129',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Innovative Treatments for Tomorrow',\n",
       "   'assetURL': 'https://example.com/assets/7609',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Simponi® (golimumab) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. Common side effects include upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients should be tested for latent tuberculosis prior to starting therapy. Consult the full prescribing information for detailed usage instructions and safety warnings.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/2971',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/7220',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/1509',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Awareness',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/7347',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/6407',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Cancer Treatment',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Ibrance® (palbociclib) is an oral kinase inhibitor indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy. Common side effects include neutropenia, infections, fatigue, and nausea. Monitor patients for hematologic toxicities and adjust dosages as necessary. Refer to the full prescribing information for complete details on indications, dosage, and safety guidelines.',\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/1610',\n",
       "   'assetType': 'Single Frame',\n",
       "   'dimensions': '160x600'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/5079',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/4820',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/9716',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '970x250'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'Image',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Arthritis',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Promotional',\n",
       "   'fullPrescribingInformation': \"Stelara® (ustekinumab) is a monoclonal antibody that targets interleukin-12 and interleukin-23, indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease. Common side effects include headache, upper respiratory infections, and injection site reactions. Regular monitoring is recommended for infections and tuberculosis. Refer to the full prescribing information for detailed guidance on administration and precautions.\",\n",
       "   'headline': 'Relief is Within Reach',\n",
       "   'assetURL': 'https://example.com/assets/6631',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '728x90'},\n",
       "  'reference': None},\n",
       " {'advertisement': {'assetSubType': 'GIF',\n",
       "   'audience': 'Consumer',\n",
       "   'indicationAndUsage': 'Immunology',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Protect Your Health Today',\n",
       "   'assetURL': 'https://example.com/assets/4858',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'},\n",
       "  'reference': None}]"
      ]
     },
     "execution_count": 361,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(\"\"\"MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "OPTIONAL MATCH (claim)-[:HAS_REFERENCE]->(reference:Reference)\n",
    "WHERE reference IS NULL\n",
    "RETURN advertisement,reference\"\"\")\n",
    "\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 367,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/8253',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'}},\n",
       " {'advertisement': {'assetSubType': 'Video',\n",
       "   'audience': 'Medical Professional',\n",
       "   'indicationAndUsage': 'Vaccination',\n",
       "   'assetFormat': 'Banner',\n",
       "   'assetPurpose': 'Educational',\n",
       "   'fullPrescribingInformation': 'Prevnar 20® is a pneumococcal 20-valent conjugate vaccine indicated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered by the vaccine. It is recommended for use in adults 18 years of age and older. Common side effects include injection site reactions, fatigue, and muscle pain. Please consult the full prescribing information for detailed safety and usage instructions.',\n",
       "   'headline': 'Science for a Better Life',\n",
       "   'assetURL': 'https://example.com/assets/8253',\n",
       "   'assetType': 'Multi Frame',\n",
       "   'dimensions': '300x250'}}]"
      ]
     },
     "execution_count": 367,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(\"\"\"MATCH (advertisement:Advertisement)\n",
    "WHERE advertisement.assetURL = 'https://example.com/assets/8253'\n",
    "RETURN advertisement\n",
    "\"\"\")\n",
    "\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 498,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'claimText': 'Provides relief for rheumatoid arthritis symptoms.',\n",
       "  'usageCount': 25},\n",
       " {'claimText': 'Significantly delays disease progression in HR+/HER2- breast cancer.',\n",
       "  'usageCount': 25},\n",
       " {'claimText': \"Effective for Crohn's disease after failure of conventional therapy.\",\n",
       "  'usageCount': 23},\n",
       " {'claimText': 'Proven effective for adults aged 18 and older.',\n",
       "  'usageCount': 21},\n",
       " {'claimText': 'Improves progression-free survival in combination therapy.',\n",
       "  'usageCount': 21}]"
      ]
     },
     "execution_count": 498,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(\"\"\"MATCH (advertisement:Advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "WITH claim, COUNT(advertisement) AS usageCount\n",
    "RETURN claim.text AS claimText, usageCount\n",
    "ORDER BY usageCount DESC\n",
    "LIMIT 5\"\"\")\n",
    "\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 475,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'ClaimPresentInPassedAdvertisements': 'Yes'}]"
      ]
     },
     "execution_count": 475,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result = kg.query(\"\"\"MATCH (advertisement:Advertisement)-[:HAS_MLR_STATUS]->(mlrStatus:MLRStatus)\n",
    "MATCH (advertisement)-[:USES_CLAIM]->(claim:Claim)\n",
    "WHERE mlrStatus.status = 'pass' and claim.text= 'Proven effective for adults aged 18 and older.'\n",
    "RETURN CASE WHEN COUNT(*) > 0 THEN 'Yes' ELSE 'No' END AS ClaimPresentInPassedAdvertisements\"\"\")\n",
    "\n",
    "result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 446,
   "metadata": {},
   "outputs": [],
   "source": [
    "result = kg.query(\"\"\"CREATE FULLTEXT INDEX claimTextSearch FOR (c:Claim) ON EACH [c.text]\"\"\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 448,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'node.text': 'Proven effective for adults aged 18 and older.',\n",
       "  'score': 5.733086585998535},\n",
       " {'node.text': 'Proven effective for children aged 18 and older.',\n",
       "  'score': 5.048819065093994},\n",
       " {'node.text': 'Proven effective for adults aged 18 and older. (References not provided)',\n",
       "  'score': 5.014046669006348},\n",
       " {'node.text': \"Effective for Crohn's disease after failure of conventional therapy.\",\n",
       "  'score': 0.9835132360458374},\n",
       " {'node.text': \"Effective for Crohn's disease after failure of conventional therapy. (References not provided)\",\n",
       "  'score': 0.8651115298271179},\n",
       " {'node.text': 'Treats moderate to severe plaque psoriasis in adults.',\n",
       "  'score': 0.6842674016952515},\n",
       " {'node.text': 'Treats moderate to severe plaque psoriasis in adults. (References not provided)',\n",
       "  'score': 0.5984470844268799},\n",
       " {'node.text': 'Provides relief for rheumatoid arthritis symptoms.',\n",
       "  'score': 0.4882717728614807},\n",
       " {'node.text': 'Provides relief for rheumatoid arthritis symptoms. (References not provided)',\n",
       "  'score': 0.42144548892974854}]"
      ]
     },
     "execution_count": 448,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "kg.query(\"\"\"CALL db.index.fulltext.queryNodes(\"claimTextSearch\", \"Proven effective for adults aged 18 and older.\") YIELD node, score\n",
    "RETURN node.text, score\"\"\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
